Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT03934216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and efficacy of oral deucravacitinib in participants with moderate to severe ulcerative colitis (UC).
Study identification
- NCT ID
- NCT03934216
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2019 (Actual)
- Primary completion
- Jun 13, 2021 (Actual)
- Completion
- Apr 4, 2023 (Actual)
- Last update posted
- Mar 6, 2024
2019 – 2023
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connecticut Clinical Research Foundation | Bristol | Connecticut | 06010 | — |
| University of Florida | Gainesville | Florida | 32610-0316 | — |
| University of Florida | Gainesville | Florida | 32611 | — |
| Local Institution - 0048 | New Port Richey | Florida | 34653 | — |
| Local Institution - 0044 | Sweetwater | Florida | 33172 | — |
| Local Institution - 0011 | Suwanee | Georgia | 30024 | — |
| Local Institution - 0121 | Glenview | Illinois | 60026 | — |
| Texas Digestive Disease Consultants - Gastroenterology Associates - Baton Rouge | Baton Rouge | Louisiana | 70809 | — |
| Local Institution - 0018 | Shreveport | Louisiana | 71103 | — |
| Local Institution - 0047 | Chevy Chase | Maryland | 20815 | — |
| Infusion Associates | Grand Rapids | Michigan | 49525 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Local Institution - 0002 | Las Vegas | Nevada | 89123 | — |
| Local Institution - 0049 | Lake Success | New York | 11042 | — |
| New York University Langone Medical Center | New York | New York | 10016 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45218 | — |
| Penn State Health Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Local Institution - 0074 | Charleston | South Carolina | 29425 | — |
| Rapid City Medical Center | Rapid City | South Dakota | 57701 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Local Institution - 0097 | Garland | Texas | 75044 | — |
| Local Institution - 0008 | Houston | Texas | 77090 | — |
| Gastroenterology Research of San Antonio | San Antonio | Texas | 78229 | — |
| Local Institution - 0106 | San Antonio | Texas | 78229 | — |
| Texas Digestive Disease Consultants - Southlake | Southlake | Texas | 76092 | — |
| Local Institution - 0116 | Tyler | Texas | 75701 | — |
| Local Institution - 0096 | Seattle | Washington | 98101 | — |
| Swedish First Hill Campus | Seattle | Washington | 98104 | — |
| Local Institution - 0122 | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03934216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2024 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03934216 live on ClinicalTrials.gov.